Antitumor reactivity induced by liposomal MTP-PE in a liver metastasis model of colon cancer in the rat
Toos Daemen
Clinical & Experimental Metastasis, 1995
View PDFchevron_right
Liposomal prednisolone phosphate potentiates the antitumor activity of liposomal 5-fluorouracil in C26 murine colon carcinomain vivo
alina sesarman
Cancer Biology & Therapy, 2017
View PDFchevron_right
The influence of phospholipid on the physicochemical properties and anti-tumor efficacy of liposomes encapsulating cisplatin in mice bearing C26 colon carcinoma
ali badiee, Mahmoud Reza Jaafari
International Journal of Pharmaceutics, 2014
View PDFchevron_right
Chemopreventive potential of beta-Sitosterol in experimental colon cancer model - an In vitro and In vivo study
Michael Gabriel Paulraj
Bmc Complement Altern Med, 2010
View PDFchevron_right
In Vivo Double Targeting of C26 Colon Carcinoma Cells and Microenvironmental Protumor Processes Using Liposomal Simvastatin
alina sesarman
Journal of Cancer, 2018
View PDFchevron_right
Chemopreventive potential of β-Sitosterol in experimental colon cancer model - an In vitro and In vivo study
Michael Gabriel Paulraj
BMC Complementary and Alternative Medicine, 2010
View PDFchevron_right
Evaluation of Multi-Target and Single-Target Liposomal Drugs for the Treatment of Gastric Cancer
Hong-Jen Liang
Bioscience, Biotechnology, and Biochemistry, 2008
View PDFchevron_right
Pharmacokinetics and Dosimetry of 111 In/ 188 Re-Labeled PEGylated Liposomal Drugs in Two Colon Carcinoma-Bearing Mouse Models
Hsin-ell Wang, Gann Ting
Cancer Biotherapy & Radiopharmaceuticals, 2011
View PDFchevron_right
Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts
Tadao Kakizoe
Cancer Science, 2004
View PDFchevron_right
Liposomal irinotecan: formulation development and therapeutic assessment in murine xenograft models of colorectal cancer
Dawn Waterhouse
2004
View PDFchevron_right
Co-delivery of curcumin and doxorubicin in PEGylated liposomes favored the antineoplastic C26 murine colon carcinoma microenvironment
alina sesarman
Drug Delivery and Translational Research, 2018
View PDFchevron_right
Tumor Burden Talks in Cancer Treatment with PEGylated Liposomal Drugs
Gann Ting
PLoS ONE, 2013
View PDFchevron_right
Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma
Maryam Ebrahimi NIk
Scientific Reports, 2019
View PDFchevron_right
Combining doxorubicin with stearylamine-bearing liposomes elicits Th1 cytokine responses and cures metastasis in a mouse model
Sneha Ghosh
Cancer Immunology, Immunotherapy, 2020
View PDFchevron_right
articleChemopreventive potential of β-Sitosterol in experimental colon cancer model-an In vitro and In vivo study
Dr. A. Albert Baskar
2016
View PDFchevron_right
Pharmacokinetics, micro-SPECT/CT imaging and therapeutic efficacy of 188Re-DXR-liposome in C26 colon carcinoma ascites mice model
Chih-Hsien Chang
Nuclear Medicine and Biology, 2008
View PDFchevron_right
In vitro characterization of a liposomal formulation of celecoxib containing 1,2-distearoyl-sn-glycero-3-phosphocholine, cholesterol, and polyethylene glycol and its functional effects against colorectal cancer cell lines
Aslı Erdoğ
Journal of pharmaceutical sciences, 2013
View PDFchevron_right
Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor model
Gann Ting
Nuclear Medicine and Biology, 2010
View PDFchevron_right
Pegylated liposomal tumor necrosis factor-? results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil�) in soft tissue sarcoma-bearing rats
Sandra T van Tiel
International Journal of Cancer, 2002
View PDFchevron_right
Encapsulation of the topoisomerase I inhibitor GL147211C in pegylated (STEALTH) liposomes: pharmacokinetics and antitumor activity in HT29 colon tumor xenografts
Michael Amantea
PubMed, 1998
View PDFchevron_right
Biodistribution, pharmacokinetics and microSPECT/CT imaging of 188Re-bMEDA-liposome in a C26 murine colon carcinoma solid tumor animal model
Gann Ting
Anticancer research
View PDFchevron_right
Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5‐fluorouracil in vivo
Manuela Banciu
Cancer Science
View PDFchevron_right
Liposomal therapies in oncology: does one size fit all?
Hugo Prazeres
Cancer chemotherapy and pharmacology, 2018
View PDFchevron_right
Cytotoxicity of PEGylated liposomes co-loaded with novel pro-apoptotic drug NCL-240 and the MEK inhibitor cobimetinib against colon carcinoma in vitro
Edgar Luther
Journal of Controlled Release, 2015
View PDFchevron_right
Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model
Tong-hsien Chow
Anticancer research, 2009
View PDFchevron_right
Diagnostic and therapeutic evaluation of 111In-vinorelbine-liposomes in a human colorectal carcinoma HT-29/luc-bearing animal model
Gann Ting
Nuclear Medicine and Biology, 2008
View PDFchevron_right